Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes
Recommendations
As issued by the authors
Goal 1: greater use of continuous glucose monitors (CGMs) for better glycemic monitoring and management
Goal 2: further research on the accuracy, feasibility, outcomes and potential value of CGMs in end-stage kidney disease (ESKD) on hemodialysis
Goal 3: equitable access to CGM technology for patients with chronic kidney disease (CKD)
Clinical gaps: CGMs not routinely prescribed in diabetes and CKD; not Food and Drug Administration (FDA)-approved for patients with diabetes on dialysis; not routinely available to all who need them because of structural barriers; gaps can be improved with greater stakeholder collaboration, education and awareness
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →